These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34928139)

  • 21. Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
    Harda K; Szabo Z; Szabo E; Olah G; Fodor K; Szasz C; Mehes G; Schally AV; Halmos G
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29949880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of new therapeutic options for the treatment of uveal melanoma.
    Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
    FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Uveal Melanoma-Specific Aptamer for Potential Biomarker Discovery and Targeted Drug Delivery.
    Pan Z; Zhu H; Zhang Y; Liao Q; Sun Y; Wu E; Wang Y; Shi K; Zhang Y; Chen L; Ye M; Wu W
    Anal Chem; 2023 Mar; 95(11):5095-5108. PubMed ID: 36812415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells.
    Kaochar S; Dong J; Torres M; Rajapakshe K; Nikolos F; Davis CM; Ehli EA; Coarfa C; Mitsiades N; Poulaki V
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):132-143. PubMed ID: 29332125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DNA-PKcs activity re-sensitizes uveal melanoma cells to radio- and chemotherapy.
    Zhang B; Wu H; Hao J; Wu Y; Yang B
    Biochem Biophys Res Commun; 2020 Feb; 522(3):639-646. PubMed ID: 31785810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
    Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
    Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.
    Landreville S; Agapova OA; Matatall KA; Kneass ZT; Onken MD; Lee RS; Bowcock AM; Harbour JW
    Clin Cancer Res; 2012 Jan; 18(2):408-16. PubMed ID: 22038994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma.
    Chua V; Orloff M; Teh JL; Sugase T; Liao C; Purwin TJ; Lam BQ; Terai M; Ambrosini G; Carvajal RD; Schwartz G; Sato T; Aplin AE
    EMBO Mol Med; 2019 Feb; 11(2):. PubMed ID: 30610113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.
    Ambrosini G; Sawle AD; Musi E; Schwartz GK
    Oncotarget; 2015 Oct; 6(32):33397-409. PubMed ID: 26397223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma.
    Jin Y; Zhang P; Wang Y; Jin B; Zhou J; Zhang J; Pan J
    Clin Cancer Res; 2018 Aug; 24(15):3741-3754. PubMed ID: 29233905
    [No Abstract]   [Full Text] [Related]  

  • 32. Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.
    Amirouchene-Angelozzi N; Nemati F; Gentien D; Nicolas A; Dumont A; Carita G; Camonis J; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Sastre X; Decaudin D; Roman-Roman S
    Mol Oncol; 2014 Dec; 8(8):1508-20. PubMed ID: 24994677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism.
    van den Bosch QCC; Kiliç E; Brosens E
    Invest Ophthalmol Vis Sci; 2024 Aug; 65(10):26. PubMed ID: 39163035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA.
    Zeng C; Long M; Lu Y
    Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):35-42. PubMed ID: 36043455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
    Zhang B; Zhang J; Pan J
    Int J Oncol; 2017 Sep; 51(3):887-898. PubMed ID: 28766683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.
    Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC
    Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Let-7b overexpression leads to increased radiosensitivity of uveal melanoma cells.
    Zhou Y; Zhang L; Fan J; Jia R; Song X; Xu X; Dai L; Zhuang A; Ge S; Fan X
    Melanoma Res; 2015 Apr; 25(2):119-26. PubMed ID: 25588203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling of human uveal melanoma in zebrafish xenograft embryos.
    van der Ent W; Burrello C; Teunisse AF; Ksander BR; van der Velden PA; Jager MJ; Jochemsen AG; Snaar-Jagalska BE
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6612-22. PubMed ID: 25249605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma.
    Ge Y; Shi S; Deng JJ; Chen XP; Song Z; Liu L; Lou L; Zhang X; Xiong XF
    J Med Chem; 2021 Mar; 64(6):3131-3152. PubMed ID: 33715360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
    Zheng L; Pan J
    Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.